Nifty

:

22445.65

Sensex

:

73997.73

77.65 (0.35%)
259.28 (0.35%)

Login

Nifty
Sensex

:
:

22445.65
73997.73

77.65 (0.35%)
259.28 (0.35%)

SMS Lifesciences India Ltd.

Pharmaceuticals & Drugs

Rating :

50/99

BSE: 540679 | NSE: SMSLIFE

Watchlist

NSE BSE

692.20

23-Apr-2024

Open
High
Low
Previous Close

694.55
717.00
688.40
694.60

Volume
Traded Value (lacs)
52 Week High
52 Week Low

4863
34.11
789.90
472.05

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

208.94
42.75
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

311.80
0.22%
1.22

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
-3.54
5.91

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-3.68
-0.96

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-8.47
-5.43

P:E (Median)

8 Years
5 Years
3 Years

-
11.88
12.27

P:BV (Average)

8 Years
5 Years
3 Years

-
1.21
1.29

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
7.54
8.30

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 71.23 90.76 -21.52% 67.84 78.48 -13.56% 74.56 80.45 -7.32% 65.55 94.96 -30.97%
Expenses 62.20 82.55 -24.65% 58.37 72.04 -18.98% 69.44 71.56 -2.96% 63.03 87.91 -28.30%
EBITDA 9.02 8.21 9.87% 9.47 6.44 47.05% 5.13 8.90 -42.36% 2.52 7.05 -64.26%
EBIDTM 12.67% 9.05% 13.96% 8.20% 6.87% 11.06% 3.85% 7.43%
Other Income 0.64 0.50 28.00% 0.34 0.13 161.54% 0.58 0.30 93.33% 2.29 1.23 86.18%
Interest 2.04 1.26 61.90% 2.48 1.24 100.00% 1.82 1.18 54.24% 1.41 1.24 13.71%
Depreciation 2.55 2.03 25.62% 2.56 2.04 25.49% 2.53 1.99 27.14% 2.12 1.97 7.61%
PBT 5.07 5.42 -6.46% 4.77 3.29 44.98% 1.36 6.03 -77.45% 3.63 10.00 -63.70%
Tax 1.76 1.41 24.82% 1.66 0.66 151.52% 0.66 1.92 -65.62% 1.16 1.56 -25.64%
PAT 3.31 4.01 -17.46% 3.11 2.63 18.25% 0.70 4.11 -82.97% 2.47 8.44 -70.73%
PATM 4.65% 4.42% 4.59% 3.36% 0.94% 5.10% 3.77% 8.89%
EPS 11.05 13.37 -17.35% 10.38 8.78 18.22% 2.34 13.69 -82.91% 8.23 28.14 -70.75%

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 72.05 88.29 -18.39% 69.26 81.26 -14.77% 74.65 82.28 -9.27% 63.73 95.66 -33.38%
Expenses 62.76 78.92 -20.48% 61.40 72.99 -15.88% 72.12 73.79 -2.26% 61.45 89.23 -31.13%
EBITDA 9.29 9.38 -0.96% 7.86 8.27 -4.96% 2.53 8.49 -70.20% 2.28 6.43 -64.54%
EBIDTM 12.90% 10.62% 11.35% 10.18% 3.39% 10.31% 3.59% 6.72%
Other Income 0.58 0.49 18.37% 0.34 0.15 126.67% 0.61 0.31 96.77% 2.46 1.72 43.02%
Interest 2.34 1.67 40.12% 2.81 1.68 67.26% 2.18 1.64 32.93% 1.80 1.75 2.86%
Depreciation 3.73 2.64 41.29% 3.73 2.64 41.29% 3.70 2.59 42.86% 2.92 2.58 13.18%
PBT 3.81 5.56 -31.47% 1.66 4.10 -59.51% -2.73 4.57 - 2.37 8.75 -72.91%
Tax -0.31 1.74 - 2.10 0.98 114.29% 1.10 2.25 -51.11% 0.25 0.67 -62.69%
PAT 4.12 3.82 7.85% -0.44 3.12 - -3.83 2.32 - 2.11 8.07 -73.85%
PATM 5.72% 4.33% -0.64% 3.84% -5.13% 2.82% 3.32% 8.44%
EPS 14.24 13.19 7.96% 2.20 9.10 -75.82% -5.94 9.95 - 5.67 26.78 -78.83%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 279.18 315.24 345.63 260.26 256.92 344.15 212.99 215.89 0.00 Net Sales Growth -19.00% -8.79% 32.80% 1.30% -25.35% 61.58% -1.34% 0 Cost Of Goods Sold 151.32 190.25 208.37 139.66 162.04 230.28 132.95 120.07 0.00 Gross Profit 127.86 124.99 137.25 120.60 94.88 113.87 80.04 95.82 0.00 GP Margin 45.80% 39.65% 39.71% 46.34% 36.93% 33.09% 37.58% 44.38% 0 Total Expenditure 253.04 288.77 314.21 230.45 233.12 311.69 199.76 187.40 0.00 Power & Fuel Cost - 25.66 26.32 19.52 18.73 24.11 21.09 21.56 0.00 % Of Sales - 8.14% 7.62% 7.50% 7.29% 7.01% 9.90% 9.99% 0 Employee Cost - 34.72 32.51 27.11 23.27 20.63 17.65 16.89 0.00 % Of Sales - 11.01% 9.41% 10.42% 9.06% 5.99% 8.29% 7.82% 0 Manufacturing Exp. - 24.72 32.65 27.62 19.26 23.98 18.73 20.77 0.00 % Of Sales - 7.84% 9.45% 10.61% 7.50% 6.97% 8.79% 9.62% 0 General & Admin Exp. - 7.44 6.85 6.60 5.45 5.38 4.91 1.91 0.00 % Of Sales - 2.36% 1.98% 2.54% 2.12% 1.56% 2.31% 0.88% 0 Selling & Distn. Exp. - 5.16 6.91 6.70 4.20 6.63 4.38 6.16 0.00 % Of Sales - 1.64% 2.00% 2.57% 1.63% 1.93% 2.06% 2.85% 0 Miscellaneous Exp. - 0.81 0.59 3.23 0.16 0.66 0.05 0.04 0.00 % Of Sales - 0.26% 0.17% 1.24% 0.06% 0.19% 0.02% 0.02% 0 EBITDA 26.14 26.47 31.42 29.81 23.80 32.46 13.23 28.49 0.00 EBITDA Margin 9.36% 8.40% 9.09% 11.45% 9.26% 9.43% 6.21% 13.20% 0 Other Income 3.85 2.88 1.54 1.33 1.88 2.53 3.08 1.73 0.00 Interest 7.75 5.16 4.68 4.57 5.10 5.46 4.21 6.20 0.00 Depreciation 9.76 8.17 7.99 7.21 7.24 5.77 5.70 5.55 0.00 PBT 14.83 16.02 20.28 19.35 13.34 23.76 6.40 18.46 0.00 Tax 5.24 5.15 7.60 6.19 4.19 7.13 -0.10 5.52 0.00 Tax Rate 35.33% 28.03% 23.05% 31.99% 31.41% 30.01% -1.56% 29.90% 0.00% PAT 9.59 13.22 25.38 13.17 9.15 16.63 6.50 12.94 0.00 PAT before Minority Interest 9.59 13.22 25.38 13.17 9.15 16.63 6.50 12.94 0.00 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 3.44% 4.19% 7.34% 5.06% 3.56% 4.83% 3.05% 5.99% 0 PAT Growth -50.03% -47.91% 92.71% 43.93% -44.98% 155.85% -49.77% 0 EPS 31.97 44.07 84.60 43.90 30.50 55.43 21.67 43.13 0.00

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Net Sales 279.69 315.56 350.07 265.59 260.78 377.85 Net Sales Growth -19.51% -9.86% 31.81% 1.84% -30.98% Cost Of Goods Sold 138.62 171.41 194.68 137.04 157.88 255.87 Gross Profit 141.07 144.16 155.39 128.55 102.90 121.98 GP Margin 50.44% 45.68% 44.39% 48.40% 39.46% 32.28% Total Expenditure 257.73 286.74 315.54 235.35 235.38 343.09 Power & Fuel Cost - 29.28 30.02 21.56 20.48 25.93 % Of Sales - 9.28% 8.58% 8.12% 7.85% 6.86% Employee Cost - 43.43 39.90 30.66 26.56 23.11 % Of Sales - 13.76% 11.40% 11.54% 10.18% 6.12% Manufacturing Exp. - 28.22 35.77 29.16 20.26 24.94 % Of Sales - 8.94% 10.22% 10.98% 7.77% 6.60% General & Admin Exp. - 8.32 7.47 6.95 5.69 5.84 % Of Sales - 2.64% 2.13% 2.62% 2.18% 1.55% Selling & Distn. Exp. - 5.25 6.97 6.75 4.30 6.74 % Of Sales - 1.66% 1.99% 2.54% 1.65% 1.78% Miscellaneous Exp. - 0.84 0.72 3.23 0.21 0.66 % Of Sales - 0.27% 0.21% 1.22% 0.08% 0.17% EBITDA 21.96 28.82 34.53 30.24 25.40 34.76 EBITDA Margin 7.85% 9.13% 9.86% 11.39% 9.74% 9.20% Other Income 3.99 3.07 1.74 1.78 2.28 2.51 Interest 9.13 6.87 6.23 4.60 5.15 5.51 Depreciation 14.08 10.79 10.01 7.86 7.86 6.38 PBT 5.11 14.24 20.04 19.57 14.67 25.39 Tax 3.14 5.22 7.43 6.01 4.48 7.54 Tax Rate 61.45% 31.46% 22.70% 30.71% 30.54% 29.70% PAT 1.96 11.47 25.32 13.56 10.18 17.85 PAT before Minority Interest 4.88 11.38 25.30 13.56 10.18 17.85 Minority Interest 2.92 0.09 0.02 0.00 0.00 0.00 PAT Margin 0.70% 3.63% 7.23% 5.11% 3.90% 4.72% PAT Growth -88.69% -54.70% 86.73% 33.20% -42.97% EPS 6.53 38.23 84.40 45.20 33.93 59.50

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 164.03 151.21 126.34 113.26 104.98 88.41 81.84 0.00 Share Capital 3.02 3.02 3.02 3.02 3.02 3.02 0.01 0.01 Total Reserves 161.00 148.19 123.31 110.23 101.96 85.38 81.83 -0.01 Non-Current Liabilities 62.80 41.83 40.41 35.93 37.42 24.36 25.41 0.00 Secured Loans 42.37 21.90 16.68 18.72 21.83 9.12 14.84 0.00 Unsecured Loans 3.60 4.95 4.95 4.95 5.38 6.08 1.13 0.00 Long Term Provisions 3.62 3.25 2.93 2.59 2.24 2.00 1.83 0.00 Current Liabilities 114.07 126.17 109.39 82.59 114.44 65.25 74.00 0.01 Trade Payables 54.53 70.85 61.63 45.33 83.83 44.39 55.40 0.01 Other Current Liabilities 24.65 18.71 21.50 12.22 10.95 12.56 7.67 0.00 Short Term Borrowings 30.11 27.14 20.20 20.96 12.77 5.99 4.04 0.00 Short Term Provisions 4.78 9.47 6.07 4.08 6.90 2.30 6.89 0.00 Total Liabilities 340.90 319.21 276.14 231.78 256.84 178.02 181.25 0.01 Net Block 139.61 98.72 100.83 94.50 87.13 68.38 72.68 0.00 Gross Block 176.07 127.71 130.82 118.16 104.26 79.79 78.34 0.00 Accumulated Depreciation 36.46 28.99 29.99 23.67 17.13 11.41 5.67 0.00 Non Current Assets 169.80 149.68 136.32 127.74 121.00 87.94 81.34 0.00 Capital Work in Progress 0.85 21.21 3.16 2.47 1.31 7.09 0.17 0.00 Non Current Investment 23.23 23.24 25.81 25.81 26.73 5.81 0.85 0.00 Long Term Loans & Adv. 6.10 6.52 5.54 4.96 4.78 5.58 4.72 0.00 Other Non Current Assets 0.00 0.00 0.97 0.00 1.05 1.08 2.92 0.00 Current Assets 171.09 169.52 139.83 104.03 135.84 90.07 99.90 0.00 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 80.46 81.36 58.76 61.05 73.87 49.32 43.79 0.00 Sundry Debtors 45.52 33.77 29.99 22.02 36.58 27.08 39.03 0.00 Cash & Bank 0.95 2.14 8.90 2.30 2.47 0.76 0.08 0.00 Other Current Assets 44.16 2.75 9.26 5.11 22.92 12.92 17.00 0.00 Short Term Loans & Adv. 41.96 49.51 32.91 13.55 12.59 6.63 9.73 0.00 Net Current Assets 57.03 43.35 30.44 21.44 21.39 24.83 25.90 -0.01 Total Assets 340.89 319.20 276.15 231.77 256.84 178.01 181.24 0.01

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Shareholder's Funds 168.61 152.23 129.22 115.73 106.33 Share Capital 3.02 3.02 3.02 3.02 3.02 Total Reserves 165.59 149.21 126.19 112.71 103.31 Non-Current Liabilities 73.11 56.38 59.00 50.06 38.60 Secured Loans 51.34 35.38 34.19 31.76 21.83 Unsecured Loans 3.60 4.95 4.95 4.95 5.38 Long Term Provisions 4.10 3.51 3.04 2.70 2.33 Current Liabilities 137.06 143.06 118.76 90.10 131.56 Trade Payables 59.67 77.89 67.03 49.03 97.91 Other Current Liabilities 42.48 28.55 25.44 15.57 13.59 Short Term Borrowings 30.11 27.14 20.20 20.96 12.77 Short Term Provisions 4.80 9.48 6.09 4.54 7.30 Total Liabilities 398.38 364.37 306.98 255.89 276.49 Net Block 228.36 142.03 129.78 124.13 117.43 Gross Block 273.58 177.21 164.01 149.59 135.78 Accumulated Depreciation 45.22 35.18 34.24 25.47 18.34 Non Current Assets 235.77 200.73 176.01 145.61 127.63 Capital Work in Progress 0.85 51.18 38.31 15.76 3.29 Non Current Investment 0.04 0.04 0.04 0.04 0.95 Long Term Loans & Adv. 6.53 7.48 6.91 5.68 4.90 Other Non Current Assets 0.00 0.00 0.97 0.00 1.05 Current Assets 162.62 163.64 130.97 110.28 148.86 Current Investments 0.00 0.00 0.00 0.00 0.00 Inventories 86.23 84.81 61.63 64.30 81.17 Sundry Debtors 46.06 33.83 34.15 21.61 41.32 Cash & Bank 4.41 4.39 11.06 7.59 2.61 Other Current Assets 25.91 2.99 11.60 5.65 23.76 Short Term Loans & Adv. 23.35 37.62 12.52 11.13 13.05 Net Current Assets 25.55 20.57 12.21 20.18 17.30 Total Assets 398.39 364.37 306.98 255.89 276.49

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 4.58 -14.66 21.62 13.95 27.26 8.00 19.66 0.00 PBT 16.02 20.28 19.35 13.34 23.76 6.40 18.46 0.00 Adjustment 11.51 10.52 9.89 10.62 8.65 7.98 8.68 0.00 Changes in Working Capital -19.45 -37.90 -3.02 -7.18 1.20 -5.62 -2.45 0.00 Cash after chg. in Working capital 8.08 -7.10 26.23 16.77 33.62 8.75 24.69 0.00 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -3.50 -7.56 -4.61 -2.82 -6.35 -0.75 -5.03 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -27.96 -7.49 -5.94 -13.28 -43.27 -6.84 -7.53 0.00 Net Fixed Assets -28.00 -14.94 -13.35 -15.06 -18.69 -8.37 -78.51 Net Investments 0.01 2.57 0.00 0.92 -20.92 -4.96 -0.85 Others 0.03 4.88 7.41 0.86 -3.66 6.49 71.83 Cash from Financing Activity 22.59 14.63 -7.87 -2.05 17.60 -0.81 -12.34 0.00 Net Cash Inflow / Outflow -0.80 -7.52 7.81 -1.38 1.60 0.36 -0.21 0.00 Opening Cash & Equivalents 0.95 8.46 0.65 2.03 0.44 0.08 0.29 0.00 Closing Cash & Equivalent 0.15 0.95 8.46 0.65 2.03 0.44 0.08 0.00

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Cash From Operating Activity 14.70 -11.24 35.17 14.55 29.99 PBT 14.24 20.04 19.57 14.67 25.38 Adjustment 15.87 14.05 10.38 11.24 9.34 Changes in Working Capital -12.15 -37.62 10.16 -8.30 1.94 Cash after chg. in Working capital 17.95 -3.53 40.10 17.61 36.67 Interest Paid 0.00 0.00 0.00 0.00 0.00 Tax Paid -3.26 -7.71 -4.93 -3.06 -6.67 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -31.29 -7.14 -26.23 -27.02 -44.01 Net Fixed Assets -28.00 -14.94 -13.35 -15.06 Net Investments 0.01 2.57 0.00 0.92 Others -3.30 5.23 -12.88 -12.88 Cash from Financing Activity 16.89 10.83 -2.55 12.45 15.37 Net Cash Inflow / Outflow 0.29 -7.55 6.39 -0.03 1.35 Opening Cash & Equivalents 0.99 8.54 2.15 2.17 0.82 Closing Cash & Equivalent 1.28 0.99 8.54 2.15 2.17

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 542.55 500.16 417.88 374.61 347.23 292.42 81838.70 -8.21 ROA 4.00% 8.53% 5.19% 3.74% 7.65% 3.62% 14.28% -14.76% ROE 8.39% 18.29% 10.99% 8.38% 17.20% 7.64% 31.63% 0.00% ROCE 10.23% 19.73% 14.36% 11.73% 21.82% 9.48% 45.72% 0.00% Fixed Asset Turnover 2.32 2.93 2.30 2.54 4.08 2.98 2.91 0.00 Receivable days 41.13 30.70 33.09 37.84 30.92 51.23 62.50 0.00 Inventory Days 83.93 67.45 76.21 87.13 59.84 72.17 70.13 0.00 Payable days 120.26 116.03 139.78 145.46 71.86 85.97 52.79 0.00 Cash Conversion Cycle 4.79 -17.88 -30.47 -20.50 18.90 37.43 79.85 0.00 Total Debt/Equity 0.52 0.40 0.35 0.43 0.45 0.31 0.32 -0.37 Interest Cover 4.56 8.05 5.24 3.61 5.35 2.52 3.98 0.00

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Book Value (Rs.) 557.71 503.53 427.40 382.80 351.70 ROA 2.98% 7.54% 4.82% 3.83% 6.45% ROE 7.09% 17.98% 11.07% 9.17% 16.78% ROCE 9.44% 18.42% 12.96% 11.91% 20.14% Fixed Asset Turnover 1.59 2.28 1.88 2.04 3.07 Receivable days 40.71 31.92 34.48 39.53 36.22 Inventory Days 87.15 68.75 77.87 91.38 71.14 Payable days 146.47 135.85 154.56 169.86 99.23 Cash Conversion Cycle -18.60 -35.18 -42.21 -38.95 8.13 Total Debt/Equity 0.59 0.51 0.50 0.55 0.44 Interest Cover 3.42 6.26 5.26 3.85 5.61

Top Investors:

harita projects private

bharadhwajan v j

Annual Reports:

News Update:

SMS Lifesciences - Quarterly Results
10th Feb 2024, 13:49 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback